Envoy Medical settles litigation with Atlas SPAC Fund I

Envoy Medical dismissed all claims in Delaware Court litigation filed by Atlas Merchant Capital regarding share redemption rights from the September 2023 SPAC merger, with no payment required from the company. Elimination of an unresolved litigation risk removes downside legal exposure, though the magnitude of potential liability was not previously disclosed.

Envoy Medical settled a lawsuit over SPAC merger share redemptions without paying anything, clearing a legal cloud that hung over the company.